Radnostix 

$0.063275
2
+$0.01+15.36% Wednesday 18:11

Statistics

Day High
0.071
Day Low
0.0575
52W High
0.11
52W Low
0.05
Volume
94,020
Avg. Volume
67,760
Mkt Cap
33.48M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

14AugExpected
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
Q1 2023
Q2 2023
-0
0
0
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-6.95%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
13.07MRevenue
-908,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow INIS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BWX Technologies
BWXT
Mkt Cap17.5B
BWX Technologies, Inc. provides nuclear components and fuel for the U.S. government, also offering isotopes for medical and industrial applications.
CPS Technologies
CPSH
Mkt Cap97.31M
CPS Technologies Corp. manufactures advanced material solutions, including components for nuclear reactors, indirectly competing in the nuclear technology sector.
Lightbridge
LTBR
Mkt Cap283.78M
Lightbridge Corporation is involved in the development of nuclear fuel technology, which could be seen as a competitor in the broader nuclear sector.
Uranium Royalty
UROY
Mkt Cap411.92M
Uranium Royalty Corp. focuses on uranium investments, indirectly competing by influencing the uranium market, which is crucial for nuclear medicine and isotopes.
Denison Mines
DNN
Mkt Cap2.9B
Denison Mines Corp. is engaged in uranium mining and exploration, indirectly affecting the supply chain for nuclear medicine and isotope production.
Ur-Energy
URG
Mkt Cap536.4M
Ur-Energy Inc. operates as a uranium mining company, indirectly competing through its role in the uranium market, impacting the nuclear sector.
Uranium Energy
UEC
Mkt Cap5.33B
Uranium Energy Corp. is a uranium mining and exploration company, indirectly competing by contributing to the uranium supply necessary for isotope production.
Cameco
CCJ
Mkt Cap42.05B
Cameco Corporation is one of the largest global providers of the uranium needed to produce nuclear energy and isotopes, indirectly competing in the supply chain.
Centrus Energy
LEU
Mkt Cap3.19B
Centrus Energy Corp. supplies enriched uranium for nuclear power, indirectly competing in the nuclear energy sector, which overlaps with isotope production.

About

Radnostix, Inc. (INIS) is a company that specializes in the global manufacturing and sale of crucial nuclear medicine calibration and reference standards, cobalt-60 products, and offers contract services for producing radiopharmaceuticals and radiochemicals. Its operations are structured into five key divisions: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Services, and Fluorine Products. The Nuclear Medicine Standards segment is responsible for creating various sources and standards essential for single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging, accurate patient positioning, and for calibrating or testing the performance of dose-measuring equipment within the nuclear pharmacy industry. This segment's product range includes flood sources, dose calibrators, rod sources, flexible and rigid rulers, precision spot and pen point markers, and numerous custom-designed items. The Cobalt Products division processes bulk cobalt, fabricates cobalt capsules for use in radiation therapy and diverse industrial applications, and is involved in the recycling of depleted cobalt sources. Through its Radiochemical Products segment, Radnostix develops and supplies a variety of highly pure radiochemicals, along with the generic drug product sodium iodide I-131, serving medical, industrial, and research applications. The Radiological Services segment offers specialized services such as the safe disposal of flood sources and the intricate processing of gemstones. Finally, the Fluorine Products segment focuses on producing small-scale, high-purity fluoride gas samples for qualification in various industrial applications. It also undertakes the development of critical laboratory and analytical processes required to support a planned uranium de-conversion and fluorine extraction facility. Radnostix, Inc. distributes its products directly to end-users as well as through a network of distributors. The company was founded in 1995 and is headquartered in Idaho Falls, Idaho.
Show more...
CEO
Mr. Shahe Bagerdjian
Employees
41
Country
United States
ISIN
US45972C1027

Listings

0 Comments

Share your thoughts

FAQ

What is Radnostix stock price today?
The current price of INIS is $0.06 USD — it has increased by +15.36% in the past 24 hours. Watch Radnostix stock price performance more closely on the chart.
What is Radnostix stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Radnostix stocks are traded under the ticker INIS.
Is Radnostix stock price growing?
INIS stock has fallen by -9.61% compared to the previous week, the month change is a -9.61% fall, over the last year Radnostix has showed a -19.91% decrease.
What is Radnostix market cap?
Today Radnostix has the market capitalization of 33.48M
What is Radnostix revenue for the last year?
Radnostix revenue for the last year amounts to 13.07M USD.
What is Radnostix net income for the last year?
INIS net income for the last year is -908,000 USD.
How many employees does Radnostix have?
As of July 09, 2026, the company has 41 employees.
In which sector is Radnostix located?
Radnostix operates in the Health & Wellness sector.
When did Radnostix complete a stock split?
Radnostix has not had any recent stock splits.
Where is Radnostix headquartered?
Radnostix is headquartered in Idaho Falls, United States.